1. Home
  2. WEN vs INBX Comparison

WEN vs INBX Comparison

Compare WEN & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wendy's Company (The)

WEN

Wendy's Company (The)

HOLD

Current Price

$7.22

Market Cap

1.4B

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$68.75

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEN
INBX
Founded
1969
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
1999
2024

Fundamental Metrics

Financial Performance
Metric
WEN
INBX
Price
$7.22
$68.75
Analyst Decision
Hold
Hold
Analyst Count
22
2
Target Price
$8.88
N/A
AVG Volume (30 Days)
9.8M
133.7K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
7.77%
N/A
EPS Growth
N/A
649.90
EPS
0.85
N/A
Revenue
$2,176,891,000.00
$200,000.00
Revenue This Year
$2.44
$563.00
Revenue Next Year
$0.99
N/A
P/E Ratio
$8.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.73
$10.81
52 Week High
$15.51
$94.57

Technical Indicators

Market Signals
Indicator
WEN
INBX
Relative Strength Index (RSI) 44.30 39.56
Support Level $6.73 $28.54
Resistance Level $8.74 $85.97
Average True Range (ATR) 0.30 4.31
MACD -0.02 -0.72
Stochastic Oscillator 46.05 11.86

Price Performance

Historical Comparison
WEN
INBX

About WEN Wendy's Company (The)

The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: